CRISPR-Cas is a defense system that evolved in single-celled organisms to target and destroy viruses. Researchers have harnessed the precision-targeting nature of this exquisitely sensitive system to edit specific sections of DNA and RNA, from any organism, in a wide range of applications.
From Pandemic to Endemic? Plus, What’s Up with the Delta Variant?
While the world watches, the viral agent that causes COVID-19 is morphing from the driver of a pandemic to one that may become endemic in humans. This is truly one for the history books.
Adaptive Immune Responses after Natural Infection and Vaccination
Daniela Weiskopf, Research Assistant Professor at La Jolla Institute for Immunology
November 30, 2021
1:00 pm – 2:00 pm ET
Transitioning From The Lab To The Business Side of Science
William Arteca, Scientific Solutions Lead, Sanguine Biosciences
December 3, 2021
1:00 pm – 3:00 pm ET
Elevated IgG Antibody to Aluminum Bound to Human Serum Albumin in Patients with Crohn’s, Celiac and Alzheimer’s Disease
Vojdani Toxics (2021)
Flow adhesion of whole blood to P-selectin: a prognostic biomarker for vaso-occlusive crisis in sickle cell disease
Hines, Callaghan, Zaidi et al Br J Haematol (2021)
